Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acid.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001923:Brain Chemistry; D002628:Chemoreceptor Cells; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism*; D005246:Feedback; D006220:Haloperidol / Q000494:pharmacology; D006885:Hydroxybutyrates / Q000494:pharmacology*; D008297:Male; D009526:Nialamide / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology
D006885:Hydroxybutyrates; D011189:Potassium Chloride; D012110:Reserpine; D000661:Amphetamine; D006220:Haloperidol; D001058:Apomorphine; D009526:Nialamide; D004298:Dopamine